NCT07277608 Clinical Characteristics and Molecular Mechanism of Patients With Obstructive Sleep Apnea
| NCT ID | NCT07277608 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Capital Medical University |
| Condition | Obstructive Sleep Apnea |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2023-08-07 |
| Primary Completion | 2033-08-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2023-08-07 with a primary completion date of 2033-08-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To clarify the clinical features of patients with obstructive sleep apnea; To construct a multi-omics database of patients with obstructive sleep apnea, and compare the effects of different degrees of sleep apnea on prognosis, immunity, and metabolism. The medium and long-term prognosis, complications, comorbidities, risk factors, and immune and metabolic dynamics of patients with sleep apnea after treatment were studied. To elucidate the biomarkers and therapeutic targets associated with obstructive sleep apnea.
Eligibility Criteria
Inclusion Criteria: * Patients with suspected obstructive sleep apnea (OSA) admitted to the sleep center of the respiratory Department of Beijing Chaoyang Hospital, Capital Medical University. * Volunteer to participate in the study and sign an informed consent, and can complete at least 1 year of follow-up. Exclusion Criteria: * Patients with obstructive sleep apnea who have been treated with impermanent positive pressure ventilation; * Pregnant or lactating women; * Patients with severe respiratory failure requiring mechanical ventilation; * Patients with severe heart, lung, liver, kidney, and central nervous system damage; * Refuse to participate in follow-up visits and/or take biological samples.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07277608 clinical trial?
This trial is open to participants of all sexes, studying Obstructive Sleep Apnea. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07277608 currently recruiting?
Yes, NCT07277608 is actively recruiting participants. Contact the research team at cysleep@163.com for enrollment information.
Where is the NCT07277608 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT07277608 clinical trial?
NCT07277608 is sponsored by Capital Medical University. The trial plans to enroll 500 participants.